Meropenem is used for: Cystic fibrosis; Intra-abdominal infections; Meningitis; Skin and skin structure infections; Diabetic foot infection.
Recorded in the NepalDoc medicine catalog for Meropenem.
Meropenem for Injection, USP is a penem antibacterial indicated for the treatment of: Complicated skin and skin structure infections (adult patients and pediatric patients 3 months of age and older only). Complicated intra-abdominal infections (adult and pediatric patients).
From the U.S. FDA-approved label for Meropenem. Full label: DailyMed.
Meropenem for Injection, USP is a penem antibacterial indicated for the treatment of: Complicated skin and skin structure infections (adult patients and pediatric patients 3 months of age and older only). Complicated intra-abdominal infections (adult and pediatric patients). Bacterial meningitis (pediatric patients 3 months of age and older only). To reduce the development of drug-resistant bacteria and maintain the effectiveness of Meropenem for Injection, USP and other antibacterial drugs, Meropenem for Injection, USP should only be used to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. 1.1 Complicated Skin and Skin Structure Infections (Adult Patients and Pediatric Patients 3 Months of Age and Older Only) Meropenem for Injection, USP is indicated for the treatment of complicated skin and skin structure infections (cSSSI) due to Staphylococcus aureus (methicillin-susceptible isolates only), Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Enterococcus faecalis (vancomycin-susceptible isolates only), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis, and Peptostreptococcus species.
From the U.S. FDA-approved label for Meropenem. Full label: DailyMed.
500 mg every 8 hours by intravenous infusion over 15 to 30 minutes for complicated skin and skin structure infections (cSSSI) for adult patients. When treating infections caused by Pseudomonas aeruginosa, a dose of 1 gram every 8 hours is recommended. 1 gram every 8 hours by intravenous infusion over 15 minutes to 30 minutes for intra-abdominal infections for adult patients.
Directions from the U.S. FDA-approved label for Meropenem — your doctor or pharmacist may advise differently.
Meropenem for Injection, USP is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta (β)-lactams. Known hypersensitivity to product components or anaphylactic reactions to β-lactams.
Excerpt from the U.S. FDA-approved label for Meropenem. Talk to a pharmacist or doctor before use.
Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving β-lactams. Severe cutaneous adverse reactions have been reported in patients receiving Meropenem for Injection, USP. Seizures and other adverse CNS experiences have been reported during treatment. Co-administration of Meropenem for Injection, USP with valproic acid or divalproex sodium reduces the serum concentration of valproic acid potentially increasing the risk of breakthrough seizures. Clostridium difficile- associated diarrhea (ranging from mild diarrhea to fatal colitis) has been reported.
Warnings and precautions excerpt from the U.S. FDA-approved label for Meropenem — not a complete list. Talk to a pharmacist or doctor before use.
The following are discussed in greater detail in other sections of labeling: Hypersensitivity Reactions Severe Cutaneous Adverse Reactions Seizure Potential Risk of Breakthrough Seizures Due to Drug Interaction with Valproic Acid Clostridium difficile – associated Diarrhea Development of Drug-Resistant Bacteria Overgrowth of Nonsusceptible Organisms Thrombocytopenia Potential for Neuromotor Impairment Most common adverse…
Excerpt from the U.S. FDA-approved label for Meropenem — not a complete list. Talk to a pharmacist or doctor about side effects.
17 brands · 8 makers in the NepalDoc catalog — see the full Meropenem guide →
Conditions Store at 20° to 25°C (68° to 77°F). Sterile, Nonpyrogenic, Preservative-free. The container closure is not made with natural rubber latex.
Storage information from the U.S. FDA-approved label for Meropenem.
What is Ronem 250?
Ronem 250mg Injection is a Meropenem medicine made by Venus. It comes as 250mg Injection.
What is Ronem 250 used for?
Meropenem is used for Cystic fibrosis, Intra-abdominal infections, Meningitis, Skin and skin structure infections, Diabetic foot infection.
What is the generic name of Ronem 250?
The generic name of Ronem 250 is Meropenem.
Which brands of Meropenem are available in Nepal?
17 brands of Meropenem are listed in the NepalDoc catalog, from 8 makers — including Merixime 1gm Injection, Merixime 500mg Injection, Merobax 1000mg Injection, Merobax 500mg Injection, Meromac 1gm Injection, Meromac 500mg Injection.
What are the side effects of Meropenem?
The following are discussed in greater detail in other sections of labeling: Hypersensitivity Reactions Severe Cutaneous Adverse Reactions Seizure Potential Risk of Breakthrough Seizures Due to Drug Interaction with Valproic Acid Clostridium difficile – associated Diarrhea Development of Drug-Resistant Bacteria Overgrowth of Nonsusceptible Organisms Thrombocytopenia Potential for Neuromotor Impairment Most common adverse…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
